The consolidation of the pharmacy sector in the USA, as major retailers continue to compete with low-cost generic prescription drugs (Marketletters passim), is likely to take a new turn, as Wal-Mart, for instance, explores the creation of smaller stores offering health and wellness products. According to health economist Jane Sarasohn-Kahn, founder of the THINK-Health consultancy, the world's biggest retailer could be planning to leverage its information technology expertise to "get involved in chronic [disease] management with real teeth."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze